Zacks Research Analysts Decrease Earnings Estimates for MD

Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) - Equities researchers at Zacks Research reduced their Q2 2025 earnings per share estimates for Pediatrix Medical Group in a note issued to investors on Thursday, June 12th. Zacks Research analyst R. Department now anticipates that the company will earn $0.38 per share for the quarter, down from their previous forecast of $0.39. The consensus estimate for Pediatrix Medical Group's current full-year earnings is $1.38 per share. Zacks Research also issued estimates for Pediatrix Medical Group's Q3 2025 earnings at $0.36 EPS, Q4 2025 earnings at $0.37 EPS, Q2 2026 earnings at $0.38 EPS and FY2026 earnings at $1.37 EPS.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. The firm had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.17% and a positive return on equity of 17.43%. The firm's revenue was down 7.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.20 EPS.

A number of other analysts have also commented on MD. UBS Group reduced their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 12th. Macquarie increased their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. Finally, Truist Financial lowered their price target on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, Pediatrix Medical Group presently has a consensus rating of "Hold" and a consensus target price of $16.67.

Pediatrix Medical Group Price Performance

NYSE MD traded down $0.05 on Monday, reaching $13.37. 594,433 shares of the stock traded hands, compared to its average volume of 800,994. Pediatrix Medical Group has a 12 month low of $6.62 and a 12 month high of $17.67. The company has a market cap of $1.15 billion, a price-to-earnings ratio of -13.23, a P/E/G ratio of 0.93 and a beta of 1.27. The firm's fifty day simple moving average is $13.67 and its 200 day simple moving average is $13.97. The company has a quick ratio of 1.81, a current ratio of 1.81 and a debt-to-equity ratio of 0.75.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. California State Teachers Retirement System grew its position in shares of Pediatrix Medical Group by 0.9% during the 4th quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock worth $1,054,000 after buying an additional 752 shares during the period. AlphaQuest LLC boosted its holdings in Pediatrix Medical Group by 16.0% during the first quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock worth $85,000 after buying an additional 811 shares during the last quarter. SummerHaven Investment Management LLC grew its position in shares of Pediatrix Medical Group by 0.9% during the 1st quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock worth $1,628,000 after buying an additional 1,028 shares during the period. Parkside Financial Bank & Trust increased its stake in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after acquiring an additional 1,040 shares during the last quarter. Finally, Nomura Asset Management Co. Ltd. raised its position in shares of Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after acquiring an additional 1,220 shares during the period. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.